Arbutus Biopharma
ABUS
#6504
Rank
NZ$1.26 B
Marketcap
NZ$6.56
Share price
3.52%
Change (1 day)
11.33%
Change (1 year)

EPS for Arbutus Biopharma (ABUS)

EPS in 2025 (TTM): NZ-$0.44

According to Arbutus Biopharma 's latest financial reports the company's current EPS (TTM) is NZ-$0.43. In 2024 the company made an earnings per share (EPS) of NZ-$0.63 an increase over its 2023 EPS that were of NZ-$0.73.

EPS history for Arbutus Biopharma from 1998 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$0.44-29.97%
2024NZ-$0.63-13.64%
2023NZ-$0.73-4.35%
2022NZ-$0.76-44.58%
2021NZ-$1.37-17%
2020NZ-$1.65-65.4%
2019NZ-$4.77138.84%
2018NZ-$2.00-22.44%
2017NZ-$2.58-78.45%
2016NZ-$11.96424.64%
2015NZ-$2.28-20.19%
2014NZ-$2.8687.96%
2013NZ-$1.52-142.59%
2012NZ$3.57-342.7%
2011NZ-$1.47-25.82%
2010NZ-$1.9847.8%
2009NZ-$1.34-43.55%
2008NZ-$2.37158.91%
2007NZ-$0.92-111.88%
2006NZ$7.72-552.53%
2005NZ-$1.71-71.77%
2004NZ-$6.04-14.48%
2003NZ-$7.07-8.95%
2002NZ-$7.7670.07%
2001NZ-$4.5648.01%
2000NZ-$3.08-38.54%
1999NZ-$5.02-24.6%
1998NZ-$6.65

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Nymox Pharmaceutical
NYMX
NZ-$0.09908-76.92% Bahamas
NRC Health
NRC
NZ$1.16-369.23%๐Ÿ‡บ๐Ÿ‡ธ USA